Argenx

1 trends tracked about this subject — the full history, oldest to newest below.

▲ Peaking Business

Argenx is expanding its immunology portfolio through a $2.2 billion acquisition of autoimmune biotech firm Forte Biosciences.

10 sources 10 articles v 8 3h ago